Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05672745 · ClinicalTrials.gov registry record · NA
How Phenotypical Characteristics of Woebot Users Are Related to Clinical Outcomes
A NA study, sponsored by Woebot Health.
- Completed
- Registry status
- NA
- Development phase
- 256
- Enrollment target
NCT05672745 is a NA study that has completed, run by Woebot Health. The registered enrollment target is 256 participants.
The verdict
NCT05672745, a NA study, has completed, sponsored by Woebot Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 256 participants
- Enrollment target
Study Summary
The goal of this observational study is to understand the characteristics of Woebot users as they relate to clinical outcomes. The objectives it aims to address are: 1. To assess Woebot usage patterns, satisfaction ratings, self-efficacy, stress, resilience, work productivity and activity impairment, alexthymia, and bond over time based on demographic, clinical baseline levels, and attitudinal characteristics 2. Among users who present with clinical levels of anxiety or depression, to assess the contribution of demographic characteristics, attitudinal characteristics, and patterns of engagement on clinical outcomes of interest over time 3. To collect and explore attitudinal characteristics of Woebot users regarding their experiences with mental health care and perceived value of digital tools for emotional support 4. Explore meaningful subgroups of Woebot users based on demographic and attitudinal characteristics, clinical outcomes, and patterns of engagement Participants who meet study eligibility requirements will be: * invited to engage with the Woebot Life program for 8 weeks * complete survey assessments at day 3, week 4 (mid-intervention), and week 8 (end of intervention)
Interventions
- DEVICE WB-LIFE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2022-05-11 |
| Est. Completion | 2022-07-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05672745
The ClinicalTrials.gov registry entry for NCT05672745 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 256 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Woebot Health, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which WB-LIFE is the first listed.
NCT05672745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05672745 about?
NCT05672745 is a clinical study titled "How Phenotypical Characteristics of Woebot Users Are Related to Clinical Outcomes". The goal of this observational study is to understand the characteristics of Woebot users as they relate to clinical outcomes. The objectives it aims to address are: 1. To assess Woebot usage patterns, satisfaction ratings, self-efficacy, stress, resilience, work productivity and activity impairme...
What is the current status of trial NCT05672745?
This trial is currently completed. It is a NA study. The enrollment target is 256 participants. The study started on 2022-05-11. Estimated completion is 2022-07-23.
What interventions are being tested in trial NCT05672745?
The interventions under investigation include: WB-LIFE (DEVICE).
Who is sponsoring clinical trial NCT05672745?
This trial is sponsored by Woebot Health, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.